Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Suspended 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Melanoma 7Carcinoma, Renal Cell 6Neoplasm Metastasis 4Carcinoma, Transitional Cell 3Urogenital Neoplasms 2Urinary Bladder Neoplasms 2Urethral Neoplasms 2Thyroid Neoplasms 2Prostatic Neoplasms 2Penile Neoplasms 2Ovarian Neoplasms 2Nasopharyngeal Carcinoma 2Myelodysplastic Syndromes 2Leukemia, Myeloid, Acute 2Glioblastoma 2Clear-cell metastatic renal cell carcinoma 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Basal Cell 2Vulvar Neoplasms 1Ureteral Neoplasms 1Urachal adenocarcinoma 1Triple Negative Breast Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Somatostatinoma 1Sjogren's Syndrome 1Seminoma 1Scleroderma, Systemic 1Sarcoma 1Rectal Neoplasms 1

Interventions

Carboplatin 5Radiotherapy 4Radiation 3Radiotherapy, Conformal 2Platinum 2Pemetrexed 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Immunoglobulin G 2Disulfides 2Cisplatin 2Bevacizumab 21,2-diaminocyclohexaneplatinum II citrate 2veliparib 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1methoxyamine 1lazertinib 1durvalumab 1capmatinib 1Taxes 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Nivolumab 1Metformin 1Ipilimumab 1Granulocyte Colony-Stimulating Factor 1Gefitinib 1Filgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma of Lung × CTLA-4 Antigen × 30 days × Clear all
NCT04929041 2026-05-13

Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative

National Cancer Institute (NCI)

Phase 2/3 Suspended
427 enrolled
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡